Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

BUY
$197.69 - $227.29 $988 - $1,136
5 Added 2.27%
225 $51,000
Q3 2023

Nov 14, 2023

BUY
$201.05 - $221.7 $6,835 - $7,537
34 Added 18.28%
220 $44,000
Q2 2023

Aug 14, 2023

BUY
$211.93 - $241.33 $1,271 - $1,447
6 Added 3.33%
186 $44,000
Q2 2022

Aug 16, 2022

SELL
$213.86 - $277.87 $12,403 - $16,116
-58 Reduced 24.37%
180 $42,000
Q4 2021

Feb 14, 2022

BUY
$271.6 - $314.21 $21,728 - $25,136
80 Added 50.63%
238 $75,000
Q3 2021

Nov 15, 2021

BUY
$274.82 - $308.34 $15,939 - $17,883
58 Added 58.0%
158 $44,000
Q4 2020

Feb 16, 2021

BUY
$186.91 - $214.42 $18,691 - $21,442
100 New
100 $20,000

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $21.5B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Carolinas Wealth Consulting LLC Portfolio

Follow Carolinas Wealth Consulting LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Carolinas Wealth Consulting LLC, based on Form 13F filings with the SEC.

News

Stay updated on Carolinas Wealth Consulting LLC with notifications on news.